Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Taluk Headquarters Hospital, Pampady, Kottayam, Kerala, India.
Eur J Pediatr. 2021 Dec;180(12):3535-3545. doi: 10.1007/s00431-021-04091-2. Epub 2021 Jun 22.
A considerable proportion of children experience a recurrence of urinary tract infection (UTI) following the first episode. While low-dose antibiotic prophylaxis has been the mainstay for the prevention of UTI, recent evidence raised concerns over their efficacy and safety. Hence, we aim to systematically synthesize evidence on the efficacy and safety of non-antibiotic prophylactic interventions for UTI. Using keywords related to study population (children) and intervention (non-antibiotic), we searched CENTRAL, Embase, PubMed, and Web of Science for randomized controlled trials (RCTs) published until August 2020. RCTs comparing any non-antibiotic interventions with placebo/antibiotics for prevention of UTIs in children were considered eligible. We used a random-effect model to provide pooled estimates. Sixteen trials evaluating 1426 participants were included. Cranberry was as effective as antibiotic prophylaxis (RR: 0.92; 95% CI: 0.56-1.50) but better than placebo/no therapy (RR: 0.48; 95% CI: 0.28-0.80) in reducing UTI recurrence. Probiotic therapy was more effective in reducing UTI recurrence (RR: 0.52; 95% CI: 0.29-0.94) when compared with placebo. While probiotic therapy was not better than antibiotics prophylaxis in preventing UTI (RR: 0.82; 95% CI: 0.56-1.21), they have a lower risk of antibiotic resistance (RR: 0.38; 95% CI: 0.21-0.69).Conclusion: Cranberry products and probiotics are the two non-antibiotic interventions that have been chiefly evaluated, reduce the risk of UTI recurrence when compared with placebo in children with a normal urinary tract. The findings from this systematic review suggest that while cranberry and probiotics may be used, there is a definite need to identify better and more acceptable non-antibiotic interventions. What is Known: • Efficacy of the low-dose antibiotic is controversial in preventing UTI and it is associated with increase in the risk of antimicrobial resistance. • Non-antibiotic interventions such as cranberry products are effective in preventing UTI recurrence in adults. What is New: • Cranberry products are effective in reducing the recurrence of UTI in children with normal urinary tract. • Low-quality evidence suggests that probiotics can be a potential prophylactic measure to reduce recurrence of UTI in the pediatric population.
相当一部分儿童在首次尿路感染 (UTI) 发作后会复发。虽然低剂量抗生素预防一直是预防 UTI 的主要方法,但最近的证据引起了人们对其疗效和安全性的关注。因此,我们旨在系统地综合非抗生素预防干预措施预防 UTI 的疗效和安全性的证据。我们使用与研究人群(儿童)和干预措施(非抗生素)相关的关键词,在 Cochrane 中央对照试验数据库(CENTRAL)、Embase、PubMed 和 Web of Science 中搜索了截至 2020 年 8 月发表的随机对照试验 (RCT)。比较任何非抗生素干预措施与安慰剂/抗生素预防儿童尿路感染的 RCT 符合入选标准。我们使用随机效应模型提供汇总估计值。纳入了 16 项评估了 1426 名参与者的试验。与抗生素预防相比,蔓越莓(RR:0.92;95%CI:0.56-1.50),但优于安慰剂/无治疗(RR:0.48;95%CI:0.28-0.80)在减少 UTI 复发方面同样有效。与安慰剂相比,益生菌疗法在减少 UTI 复发方面更有效(RR:0.52;95%CI:0.29-0.94)。虽然益生菌疗法在预防 UTI 方面并不优于抗生素预防(RR:0.82;95%CI:0.56-1.21),但它们具有较低的抗生素耐药风险(RR:0.38;95%CI:0.21-0.69)。结论:蔓越莓产品和益生菌是两种主要评估的非抗生素干预措施,与安慰剂相比,可降低正常尿路儿童 UTI 复发的风险。本系统评价的结果表明,虽然可以使用蔓越莓和益生菌,但确实需要确定更好和更可接受的非抗生素干预措施。已知:•低剂量抗生素预防 UTI 的疗效存在争议,并且与增加抗菌药物耐药性的风险相关。•非抗生素干预措施,如蔓越莓产品,在预防成人 UTI 复发方面有效。新发现:•蔓越莓产品可有效降低正常尿路儿童 UTI 的复发率。•低质量证据表明,益生菌可能是减少儿科人群 UTI 复发的潜在预防措施。